Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
Journal article
Ashdown HF. et al, (2022), ERJ Open Research, 8, 00606 - 2021
Discordant diagnostic criteria for pneumonia in COPD trials: a review
Journal article
Wise RA. et al, (2021), European Respiratory Review, 30, 210124 - 210124
Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant
Journal article
Turnbull CD. et al, (2021), BMJ Open Respiratory Research, 8, e001044 - e001044
Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
Journal article
Singh D. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 3009 - 3016
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
Preprint
Baker JR. et al, (2021)
Renaming COPD exacerbations: the UK respiratory nursing perspective.
Journal article
Mwasuku C. et al, (2021), BMC pulmonary medicine, 21
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial (vol 398, pg 843, 2021)
Journal article
Yu L-M. et al, (2021), LANCET, 398, E12 - E12
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Yu L-M. et al, (2021), The Lancet, 398, 843 - 855
Predicting treatment outcomes following an exacerbation of airways disease
Journal article
Halner A. et al, (2021), PLOS ONE, 16, e0254425 - e0254425
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
Journal article
Bafadhel M. et al, (2021), Eur Respir J
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
Journal article
Ramakrishnan S. and Bafadhel M., (2021), Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 127
Research priorities for exacerbations of COPD.
Journal article
Alqahtani JS. et al, (2021), The Lancet. Respiratory medicine, 9, 824 - 826
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Journal article
Ramakrishnan S. et al, (2021), LANCET RESPIRATORY MEDICINE, 9, 763 - 772
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
Journal article
Pavord I. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 1755 - 1770
Inhaled budesonide for early treatment of COVID-19 - Authors' reply.
Journal article
Ramakrishnan S. and Bafadhel M., (2021), The Lancet. Respiratory medicine
Accuracy of the Albus Home Research Device (RD) for the Non-Contact and Passive Monitoring of Nocturnal Respiratory Rate at Home in an Adult Population
Conference paper
Do WI. et al, (2021), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 203
Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV1
Journal article
Cane JL. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 1437 - 1447
Pediatric Nocturnal Respiratory Rate Monitoring Using a Non-Contact and Passive Bedside Device: Accuracy of the Albus Home Research Device (RD)
Conference paper
Wheeler CJ. et al, (2021), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 203
A Comprehensive Analysis of the Stability of Blood Eosinophil Levels
Journal article
Chipps BE. et al, (2021), Annals of the American Thoracic Society
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Journal article
Yu L-M. et al, (2021)